Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage

Publication date: November 2020Source: Biomedicine & Pharmacotherapy, Volume 131Author(s): Mohamed E. Shaker, Hesham A.M. Gomaa, Khalid S. Alharbi, Mohammad M. Al-Sanea, Mohamed E. El-Mesery, Sara H. Hazem
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research